Shopping Cart
- Remove All
![TargetMol](https://newstatic.targetmol.com/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC) targeting Trop-2, facilitates the delivery of SN-38. It demonstrates anticancer activity [1]. |
In vivo | Sacituzumab govitecan (IMMU-132) administered at a dose of 17.5 mg/kg biweekly for four weeks demonstrated significant antitumor activity in mice bearing human gastric cancer xenografts [1]. |
Alias | IMMU-132 |
Molecular Weight | 160 KDa (Approximately) |
Cas No. | 1491917-83-9 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.